previously several years, the UK has witnessed a revolution in medical bodyweight‑loss remedies — through the introduction of semaglutide (Wegovy®) for the escalating acceptance of tirzepatide (Mounjaro®). Now, A different name is drawing attention in the two clinical and public wellbeing circles: Retatrutide. at this time under development